Search Results

There are 6998 results for: content related to: Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene

  1. You have full text access to this Open Access content
    New cancer treatment strategy using combination of green tea catechins and anticancer drugs

    Cancer Science

    Volume 102, Issue 2, February 2011, Pages: 317–323, Masami Suganuma, Achinto Saha and Hirota Fujiki

    Version of Record online : 30 DEC 2010, DOI: 10.1111/j.1349-7006.2010.01805.x

  2. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins

    Molecular Carcinogenesis

    Volume 46, Issue 8, August 2007, Pages: 640–645, Takashi Kuzuhara, Akitoshi Tanabe, Yoshihisa Sei, Kentaro Yamaguchi, Masami Suganuma and Hirota Fujiki

    Version of Record online : 17 APR 2007, DOI: 10.1002/mc.20332

  3. Green tea: Health benefits as cancer preventive for humans

    The Chemical Record

    Volume 5, Issue 3, 2005, Pages: 119–132, Hirota Fujiki

    Version of Record online : 11 MAY 2005, DOI: 10.1002/tcr.20039

  4. Transient receptor potential vanilloid type 1 is vital for (−)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase

    Molecular Nutrition & Food Research

    Volume 59, Issue 4, April 2015, Pages: 646–657, Bei-Chia Guo, Jeng Wei, Kuo-Hui Su, An-Na Chiang, Jin-Feng Zhao, Hsiang-Ying Chen, Song-Kun Shyue and Tzong-Shyuan Lee

    Version of Record online : 9 FEB 2015, DOI: 10.1002/mnfr.201400699

  5. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (–)-epigallocatechin-3-gallate, in oral cells

    Molecular Nutrition & Food Research

    Volume 58, Issue 4, April 2014, Pages: 665–676, Ling Tao, Sarah C. Forester and Joshua D. Lambert

    Version of Record online : 18 NOV 2013, DOI: 10.1002/mnfr.201300427

  6. Inhibition of starch digestion by the green tea polyphenol, (−)-epigallocatechin-3-gallate

    Molecular Nutrition & Food Research

    Volume 56, Issue 11, November 2012, Pages: 1647–1654, Sarah C. Forester, Yeyi Gu and Joshua D. Lambert

    Version of Record online : 5 OCT 2012, DOI: 10.1002/mnfr.201200206

  7. Differential prooxidative effects of the green tea polyphenol, (–)-epigallocatechin-3-gallate, in normal and oral cancer cells are related to differences in sirtuin 3 signaling

    Molecular Nutrition & Food Research

    Volume 59, Issue 2, February 2015, Pages: 203–211, Ling Tao, Jong-Yung Park and Joshua D. Lambert

    Version of Record online : 17 NOV 2014, DOI: 10.1002/mnfr.201400485

  8. You have free access to this content
    A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia

    British Journal of Pharmacology

    Volume 172, Issue 14, July 2015, Pages: 3565–3578, Ji Hoon Jung, Miyong Yun, Eun-Jeong Choo, Sun-Hee Kim, Myoung-Seok Jeong, Deok-Beom Jung, Hyemin Lee, Eun-Ok Kim, Nobuo Kato, Bonglee Kim, Sanjay K Srivastava, Kunihiro Kaihatsu and Sung-Hoon Kim

    Version of Record online : 4 JUN 2015, DOI: 10.1111/bph.13146

  9. Encapsulation of (−)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes

    Journal of the Science of Food and Agriculture

    Volume 96, Issue 13, October 2016, Pages: 4623–4632, Katja Istenič, Romana Cerc Korošec and Nataša Poklar Ulrih

    Version of Record online : 8 APR 2016, DOI: 10.1002/jsfa.7691

  10. You have free access to this content
    Lipid raft-associated catechin suppresses the FcϵRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2

    FEBS Letters

    Volume 556, Issue 1-3, January 02, 2004, Pages: 204–210, Yoshinori Fujimura, Hirofumi Tachibana and Koji Yamada

    Version of Record online : 11 DEC 2003, DOI: 10.1016/S0014-5793(03)01432-7

  11. You have free access to this content
    Catechin derivatives: Specific inhibitor for caspases-3, 7 and 2, and the prevention of apoptosis at the cell and animal levels

    FEBS Letters

    Volume 580, Issue 3, February 06, 2006, Pages: 741–746, Nobuhiko Katunuma, Atsushi Ohashi, Etsuko Sano, Naozumi Ishimaru, Yoshio Hayashi and Etsuko Murata

    Version of Record online : 6 JAN 2006, DOI: 10.1016/j.febslet.2005.12.087

  12. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action

    The FEBS Journal

    Volume 283, Issue 3, February 2016, Pages: 446–458, Wei Liang, Aristi P. Fernandes, Arne Holmgren, Xiaoming Li and Liangwei Zhong

    Version of Record online : 26 NOV 2015, DOI: 10.1111/febs.13587

  13. You have free access to this content
    EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP

    FEBS Letters

    Volume 584, Issue 19, October 08, 2010, Pages: 4259–4267, Jamie Winderbaum Fernandez, Kavon Rezai-Zadeh, Demian Obregon and Jun Tan

    Version of Record online : 17 SEP 2010, DOI: 10.1016/j.febslet.2010.09.022

  14. You have free access to this content
    Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers

    European Journal of Heart Failure

    Volume 10, Issue 5, May 2008, Pages: 439–445, Mario Lorenz, Niels Hellige, Philipp Rieder, Hans-Tilmann Kinkel, Christiane Trimpert, Alexander Staudt, Stephan B. Felix, Gert Baumann, Karl Stangl and Verena Stangl

    Version of Record online : 13 JAN 2014, DOI: 10.1016/j.ejheart.2008.03.004

  15. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate

    Journal of Cellular Physiology

    Volume 202, Issue 1, January 2005, Pages: 295–303, David W. Scott, Sophia Mutamba, Robin G. Hopkins and George Loo

    Version of Record online : 12 AUG 2004, DOI: 10.1002/jcp.20135

  16. Systematic characterization of the covalent interactions between (−)-epigallocatechin gallate and peptides under physiological conditions by mass spectrometry

    Rapid Communications in Mass Spectrometry

    Volume 23, Issue 8, 30 April 2009, Pages: 1147–1157, Dong Cao, Yangjun Zhang, Huihui Zhang, Liangwei Zhong and Xiaohong Qian

    Version of Record online : 11 MAR 2009, DOI: 10.1002/rcm.3985

  17. Docking studies and model development of tea polyphenol proteasome inhibitors: Applications to rational drug design

    Proteins: Structure, Function, and Bioinformatics

    Volume 54, Issue 1, 1 January 2004, Pages: 58–70, David M. Smith, Kenyon G. Daniel, Zhigang Wang, Wayne C. Guida, Tak-Hang Chan and Q. Ping Dou

    Version of Record online : 4 SEP 2003, DOI: 10.1002/prot.10504

  18. You have free access to this content
    Inhibitory Effect of (−)-Epigallocatechin-3-Gallate on Lipid Accumulation of 3T3-L1 Cells


    Volume 15, Issue 11, November 2007, Pages: 2571–2582, Hyun-Seuk Moon, Chung-Soo Chung, Hong-Gu Lee, Tae-Gyu Kim, Yun-Jaie Choi and Chong-Su Cho

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.309

  19. Production of Epigallocatechin Gallate 7- O-α-d-Glucopyranoside (EGCG-G1) Using the Glucosyltransferase from Leuconostoc mesenteroides

    Biotechnology Progress

    Volume 23, Issue 5, 2007, Pages: 1082–1086, Eun-Kyung Hyun, Ha-Young Park, Hye-Jung Kim, Jung-Kul Lee, Doman Kim and Deok-Kun Oh

    Version of Record online : 5 SEP 2008, DOI: 10.1021/bp0700657

  20. You have free access to this content
    Carbonyl reductase 1 as a novel target of (−)-epigallocatechin gallate against hepatocellular carcinoma


    Volume 52, Issue 2, August 2010, Pages: 703–714, Weixue Huang, Liya Ding, Qiang Huang, Hairong Hu, Shan Liu, Xianmei Yang, Xiaohui Hu, Yongjun Dang, Suqin Shen, Jie Li, Xiaona Ji, Songmin Jiang, Jun O. Liu and Long Yu

    Version of Record online : 19 APR 2010, DOI: 10.1002/hep.23723